Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q2 2014 (← Previous) (Next →)
Filing Date: Aug 14, 2014
Total Value: $632M (93.1% shares, 6.9% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IRWD | IRONWOOD PHARMACEUTICALS INC | 9,208,909 | $141M | 22.3% | — | — | COM CL A | 46333X108 |
| LGND | LIGAND PHARMACEUTICALS INC | 1,893,123 | $118M | 18.6% | — | — | COM NEW | 53220K504 |
| — | ARRAY BIOPHARMA INC | 14,715,786 | $67.1M | 10.6% | — | — | COM | 04269X105 |
| — | CHEMOCENTRYX INC | 8,181,816 | $47.86M | 7.6% | — | — | COM | 16383L106 |
| — | RECEPTOS INC | 910,600 | $38.79M | 6.1% | — | — | COM | 756207106 |
| — | ONCOTHYREON INC | 9,858,278 | $31.94M | 5.1% | — | — | COM | 682324108 |
| — | TARGACEPT INC | 6,655,128 | $30.02M | 4.7% | — | — | COM | 87611R306 |
| — | EXELIXIS INC | 29,725,000 | $25.27M | 4.0% | — | — | NOTE 4.250% 8/1 | 30161QAC8 |
| — | FIVE PRIME THERAPEUTICS INC | 1,253,000 | $19.48M | 3.1% | — | — | COM | 33830X104 |
| — | ONCOMED PHARMACEUTICALS INC | 825,647 | $19.24M | 3.0% | — | — | COM | 68234X102 |
| — | ARRAY BIOPHARMA INC | 18,500,000 | $18.52M | 2.9% | — | — | NOTE 3.000% 6/0 | 04269XAA3 |
| — | REGADO BIOSCIENCES INC | 2,607,091 | $17.7M | 2.8% | — | — | COM | 75874Q107 |
| — | QLT INC | 2,370,263 | $14.65M | 2.3% | — | — | COM | 746927102 |
| — | TREVENA INC | 1,118,743 | $6.321M | 1.0% | — | — | COM | 89532E109 |
| CYTK | CYTOKINETICS INC | 1,317,000 | $6.295M | 1.0% | — | — | COM NEW | 23282W605 |
| — | ARQULE INC | 3,124,887 | $4.844M | 0.8% | — | — | COM | 04269E107 |
| EXEL | EXELIXIS INC | 1,000,000 | $3.39M | 0.5% | — | — | COM | 30161Q104 |
| — | ONCOGENEX PHARMACEUTICALS IN | 862,069 | $3.216M | 0.5% | — | — | COM | 68230A106 |
| — | BIOLINERX LTD | 1,501,000 | $3.122M | 0.5% | — | — | SPONSORED ADR | 09071M106 |
| — | KALOBIOS PHARMACEUTICALS INC | 1,162,000 | $2.649M | 0.4% | — | — | COM | 48344T100 |
| — | ANTHERA PHARMACEUTICALS INC | 559,624 | $1.897M | 0.3% | — | — | COM NEW | 03674U201 |
| — | ACHAOGEN INC | 125,000 | $1.745M | 0.3% | — | — | COM | 004449104 |
| QURE | UNIQURE NV | 125,000 | $1.699M | 0.3% | — | — | SHS | N90064101 |
| — | PALATIN TECHNOLOGIES INC | 1,610,652 | $1.595M | 0.3% | — | — | COM PAR $ .01 | 696077403 |
| — | BIND THERAPEUTICS INC | 116,000 | $1.529M | 0.2% | — | — | COM | 05548N107 |
| — | REGULUS THERAPEUTICS INC | 184,999 | $1.487M | 0.2% | — | — | COM | 75915K101 |
| — | SOPHIRIS BIO INC | 600,000 | $1.344M | 0.2% | — | — | COM NEW | 83578Q209 |
| — | BIOTA PHARMACEUTIALS INC | 435,900 | $1.242M | 0.2% | — | — | COM | 090694100 |
| — | TRANSCEPT PHARMACEUTICALS IN | 150,000 | $299K | 0.0% | — | — | COM | 89354M106 |